Franklin Beninsig has been appointed vice president of licensing and intellectual property for LifeWave (Sacramento, California). Beninsig has served as an intellectual property expert or litigation/ discovery coordinator for several law firms, including Fish & Richardson. His primary responsibilities will include the launch of LifeWave's LifeScanner licensing program for medical devices. The LifeScanner device is a non-invasive, non-contact medical radar for cardiopulmonary evaluation, monitoring and management.

Omnisonics Medical Technologies (Wilmington, Massachusetts) has named Daniel Geffken senior vice president and chief financial officer. Geffken previously held the same posts at Transkaryotic Therapies. OmniSonics develops medical devices to treat vascular occlusive disease, based on its OmniWave Technology, enabling the delivery of acoustic energy over the active length of a small diameter wire in an occluded blood vessel.

Philip Theodore has been named vice president, general counsel and corporate secretary of Serologicals (Atlanta, Georgia). Theodore will serve as an officer of the corporation and as a member of the executive operating committee. Previously, he was a partner with the law firm King & Spalding. Serologicals is a global provider of biological products and enabling technologies, used within the areas of oncology, hematology, immunology, cardiology and infectious diseases, as well as in the study of molecular biology.

St. Jude Medical (St.Paul, Minnesota) reported that Chairman and Chief Executive Officer Terry Shepherd has decided to retire, effective with the company's annual meeting in May 2004. The board of directors has elected President and Chief Operating Officer Daniel Starks to succeed Shepherd as CEO and chairman of the board, upon Shepherd's retirement. Shepherd also will retire from the board of directors at that time. St. Jude Medical is a manufacturer of mechanical and tissue heart valves, pacemakers, implantable cardioverter defibrillators and electrophysiology catheters.

Alex Derchak, PhD, has joined VivoMetrics (Ventura, California) as director of clinical research. Derchak previously was a senior scientific communications associate in the global scientific information and communications at Eli Lilly. VivoMetrics develops continuous ambulatory monitoring products and services, its lead product being the LifeShirt System, a non-invasive system that collects data on cardiac and respiratory function and other physiological parameters.